Total synthesis and antitumor activity of ZK-EPO: the first fully synthetic epothilone in clinical development.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Angewandte Chemie

• Publication date

  2006-12-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/ANIE.200602785PMID 17006870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epothilones in the treatment of cancer

  2006cited by this paper
• Efficient Chiral Pool Synthesis of the C1-C6 Fragment of Epothilones

  2005cited by this paper
• The epothilones and related analogues-a review of their syntheses and anti-cancer activities.

  2005cited by this paper
• The merger of natural product synthesis and medicinal chemistry: on the chemistry and chemical biology of epothilones.

  2004cited by this paper
• Recent Progress in the Synthesis of Epothilones

  2004cited by this paper
• Conformation-activity relationships in polyketide natural products: a new perspective on the rational design of epothilone analogues.

  2003cited by this paper
• Epothilones: new tubulin polymerization agents in preclinical and clinical development

  2002cited by this paper
• BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

  2001cited by this paper
• Subcellular distribution of epothilones in human tumor cells

  2001cited by this paper
• Synthesis and biological evaluation of highly potent analogues of epothilones B and D.

  2000cited by this paper
• Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.

  2000cited by this paper
• A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products

  2000cited by this paper
• Complex Target-Oriented Synthesis in the Drug Discovery Process: A Case History in the dEpoB Series

  1999cited by this paper
• The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells

  1999cited by this paper
• Syntheses of (−)‐Epothilone B

  1999cited by this paper
• Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.

  1998cited by this paper
• Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.

  1998cited by this paper
• REMOTE EFFECTS IN MACROLIDE FORMATION THROUGH RING-FORMING OLEFIN METATHESIS : AN APPLICATION TO THE SYNTHESIS OF FULLY ACTIVE EPOTHILONE CONGENERS

  1997cited by this paper
• Total Syntheses of Epothilones A and B via a Macrolactonization-Based Strategy

  1997cited by this paper
• An Oxyallyl (or Oxyallyl-like) Geometry Is a Key Structure in the Reaction of Ketenes and Diazoalkanes To Form Cyclopropanones

  1997cited by this paper
• Total Synthesis of Epothilone A: The Olefin Metathesis Approach

  1997cited by this paper
• Totalsynthese von (−)-Epothilon A†

  1997cited by this paper
• DIE TOTALSYNTHESE VON EPOTHILON A : DER ZUGANG DURCH OLEFINMETATHESE

  1997cited by this paper
• Total Syntheses of Epothilones A and B

  1997cited by this paper
• Total Synthesis of (−)‐Epothilone A

  1997cited by this paper
• Epothilon A und B – neuartige, 16gliedrige Makrolide mit cytotoxischer Wirkung: Isolierung, Struktur im Kristall und Konformation in Lösung†

  1996cited by this paper
• Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties.

  1996cited by this paper
• Epothilone A and B—Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution†

  1996cited by this paper
• Total Synthesis of Epothilone A.

  1996cited by this paper
• Totalsynthese von (—)‐Epothilon A

  1996cited by this paper
• Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.

  1995cited by this paper
• Synthesis of the Enantiomers of 2, 6-Dimethyl-6-hepten-1-ol, a Mandibular Gland Secretion of the Male Ant Lasius niger

  1991cited by this paper
• Improved Carbon‐Carbon Linking by Controlled Copper Catalysis

  1974cited by this paper
• Bessere CC‐Verknüpfungen durch kontrollierte Kupfer‐Katalyse

  1974cited by this paper

• Synthesis and Early Assessment of Epothilone‐Derived Fluorescent Probes for Microtubule Imaging

  2026cites this paper
• A modified all-in-one DMSO-activating and base releasing reagent for the Parikh-Doering-type benzylic oxidation reaction

  2024cites this paper
• Modern Strategies for Carbon Isotope Exchange.

  2023cites this paper
• Deciphering the Mechanism of Action of Armeniaspirol: A Polyketide Gram-Positive Antibiotic

  2021cites this paper
• Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases

  2021cites this paper
• Drug-Induced Peripheral Neuropathy: Diagnosis and Management.

  2021cites this paper
• Design and Synthesis of Simplified Polyketide Analogs: New Modalities beyond the Rule of 5

  2021cites this paper
• An overview on anti-tubulin agents for the treatment of lymphoma patients.

  2020cites this paper
• The progress of the anticancer agents related to the microtubules target.

  2020cites this paper
• Epoxide containing molecules: A good or a bad drug design approach.

  2020cites this paper
• Navigating around Patented Routes by Preserving Specific Motifs along Computer-Planned Retrosynthetic Pathways

  2019cites this paper
• Towards modern anticancer agents that interact with tubulin

  2019cites this paper
• Structural mechanism of regioselectivity in an unusual bacterial acyl-CoA dehydrogenase

  2019cites this paper
• Repositioning Microtubule Stabilizing Drugs for Brain Disorders

  2018cites this paper
• Total syntheses of the archazolids: an emerging class of novel anticancer drugs

  2017cites this paper
• Exploring the Boundaries of "Practical": De Novo Syntheses of Complex Natural Product-Based Drug Candidates.

  2017cites this paper
• Synthesis and Evaluation of a Linkable Functional Group-Equipped Analogue of the Epothilones.

  2017cites this paper
• Synthetic Approaches Used in the Scale‐Up of Macrocyclic Clinical Candidates

  2017cites this paper
• Synthesis of Alkenylboronic Esters: An Alternative Route to Trisubstituted Homoallylic Alcohols

  2016cites this paper
• The Role of Natural Products in Drug Discovery

  2015cites this paper
• Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy

  2015cites this paper
• Chapter 9 – Anticancer Drugs Targeting Tubulin and Microtubules

  2015cites this paper
• Biocatalysis at Work: Applications in the Development of Sagopilone

  2015cites this paper
• Selected hybrid natural products as tubulin modulators.

  2015cites this paper
• A Highly Stereoselective, Efficient, and Scalable Synthesis of the C(1)-C(9) Fragment of the Epothilones.

  2015cites this paper
• Stereoselective synthesis of higher homologues of pantolactone from (R)-glyceraldehyde acetonide

  2015cites this paper
• Recent advances in the synthesis of 2-substituted benzothiazoles: a review

  2014cites this paper
• Small-molecule clinical trial candidates for the treatment of glioma.

  2014cites this paper
• Integrative oncology drug discovery accompanied by preclinical translational research as prerequisite for clinical development.

  2014cites this paper
• Chemistry and Biology of Epothilones

  2014cites this paper
• Natural product chemistry and anticancer drug discovery

  2014cites this paper
• Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer.

  2013cites this paper
• Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs

  2013cites this paper
• Natural products: a continuing source of novel drug leads.

  2013cites this paper
• Natural Product Scaffolds in Cancer Therapy

  2013cites this paper
• First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumors

  2012cites this paper
• Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

  2012cites this paper
• Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

  2012cites this paper
• Vereinigung von chemischer Synthese und Biosynthese: ein neues Kapitel in der Totalsynthese von Naturstoffen und Naturstoffbibliotheken

  2012cites this paper
• 2.10 Chiral Pool Synthesis: Chiral Pool Synthesis from Hydroxy Acids: Lactic Acid, Tartaric Acid, Malic Acid, and 2-Methyl-3-hydroxypropionic Acid

  2012cites this paper
• Merging chemical synthesis and biosynthesis: a new chapter in the total synthesis of natural products and natural product libraries.

  2012cites this paper
• New Insights into Tubulin Binders

  2011cites this paper
• Hydrophobic 1-allyl-3-alkylimidazolium dicyanamide ionic liquids with low densities

  2011cites this paper
• Evaluation of Activity and Combination Strategies with the Microtubule-Targeting Drug Sagopilone in Breast Cancer Cell Lines

  2011cites this paper
• Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives

  2011influential citation
• The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivo

  2011cites this paper
• Molecular Mode of Action and Role of TP53 in the Sensitivity to the Novel Epothilone Sagopilone (ZK-EPO) in A549 Non-Small Cell Lung Cancer Cells

  2011cites this paper
• Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

  2011cites this paper
• Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group

  2011cites this paper
• C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle.

  2011cites this paper
• A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer.

  2011cites this paper
• Natural Products in Drug Discovery: Impacts and Opportunities — An Assessment

  2011cites this paper
• Natural products: an evolving role in future drug discovery.

  2011cites this paper
• Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines.

  2010cites this paper
• Microbes to Man: From Soils and the Depths to Drugs

  2010cites this paper
• Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer

  2010influential citation
• Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery.

  2010cites this paper
• Treatment of cutaneous melanoma: current approaches and future prospects

  2010cites this paper
• Improving the ex vivo stability of drug ester compounds in rat and dog serum: inhibition of the specific esterases and implications on their identity.

  2010cites this paper
• Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors.

  2010cites this paper
• NRPS/PKS hybrid enzymes and their natural products

  2010cites this paper
• Treatment of cutaneous melanoma : current approaches and future prospects

  2010cites this paper
• Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma

  2010cites this paper
• (-)-Bacillamide C: the convergent approach.

  2010cites this paper
• Polymeric micelles for parenteral delivery of sagopilone: physicochemical characterization, novel formulation approaches and their toxicity assessment in vitro as well as in vivo.

  2010cites this paper
• Recent Applications of Alkene Metathesis in Fine Chemical Synthesis

  2010cites this paper
• Natural product scaffolds as leads to drugs.

  2009cites this paper
• Epothilones: tubulin polymerization as a novel target for prostate cancer therapy

  2009cites this paper
• Sagopilone Inhibits Breast Cancer Bone Metastasis and Bone Destruction Due to Simultaneous Inhibition of Both Tumor Growth and Bone Resorption

  2009cites this paper
• Untersuchung des molekularen Wirkmechanismus des vollsynthetischen Epothilons Sagopilon

  2009influential citation
• Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial

  2009cites this paper
• Novel cyclic sulfonium-based ionic liquids: synthesis, characterization, and physicochemical properties.

  2009cites this paper
• Muscarine, imidazole, oxazole and thiazole alkaloids.

  2009cites this paper
• Macrolide-based microtubule-stabilizing agents - chemistry and structure-activity relationships.

  2009cites this paper
• Novel microtubule-targeting agents – the epothilones Kit

  2009cites this paper
• Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.

  2009cites this paper
• Sagopilone, a microtubule stabilizer for the potential treatment of cancer.

  2009cites this paper
• Microbial antitumor drugs: natural products of microbial origin as anticancer agents.

  2009cites this paper
• Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.

  2009cites this paper
• Preparation, modification, and evaluation of cruentaren A and analogues.

  2009cites this paper
• Preclinical pharmacology and structure-activity studies of epothilones.

  2009cites this paper
• Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.

  2009cites this paper
• Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.

  2009cites this paper
• DEVELOPMENT, CHARACTERIZATION AND IMAGING OF BONE METASTASIS MOUSE MODELS - THE EFFECT OF SAGOPILONE ON TUMOR GROWTH AND BONE RESORPTION -

  2009cites this paper
• Total synthesis of epothilones A-F.

  2009cites this paper
• Chapter 15 Case History: Discovery of Ixabepilone (IXEMPRATM), a First-in-Class Epothilone Analog for Treatment of Metastatic Breast Cancer

  2009cites this paper
• Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system.

  2009cites this paper
• Molecular mode of action and mechanism of resistance of the microtubule-stabilizing drug Sagopilone

  2009cites this paper
• Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas

  2009cites this paper
• The Epothilones: How Pharmacology Relates to Clinical Utility

  2009cites this paper
• Isolierung, Identifizierung und Inhibition von Esterasen aus Ratten- und Hundeserum zur Stabilisierung von Serumproben ex vivo im Rahmen der präklinischen Arzneimittelentwicklung

  2009cites this paper
• Natural Products as Anticancer Agents

  2008cites this paper
• Total synthesis and selective activity of a new class of conformationally restrained epothilones.

  2008cites this paper
• Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo

  2008cites this paper
• Selected substituent effects on the rate and efficiency of formation of an eight-membered ring by RCM.

  2008cites this paper
• Discovery and Development of the Epothilones

  2008cites this paper
• Design and synthesis of C6-C8 bridged epothilone A.

  2008cites this paper
• Tubulin-interactive natural products as anticancer agents.

  2008cites this paper
• MicrotubuleActiveAgents : Beyond theTaxane Frontier

  2008cites this paper
• Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.

  2008cites this paper